PUBLISHER: The Business Research Company | PRODUCT CODE: 1539634
PUBLISHER: The Business Research Company | PRODUCT CODE: 1539634
A brain pacemaker, an implantable medical device, treats neurological conditions such as Parkinson's disease and epilepsy. It involves electrodes implanted in specific brain regions linked to a pulse generator in the chest. This device sends electrical impulses to regulate abnormal brain activity.
Brain pacemakers come in two main types single channel and dual channel. A single channel brain pacemaker delivers electrical stimulation to one brain area, addressing conditions such as dystonia, epilepsy, essential tremor, obsessive-compulsive disorder, Parkinson's disease, among others. These devices are distributed through both channel and direct sales, targeting end users such as hospitals, ambulatory surgical centers, and clinics.
The brain pacemaker market research report is one of a series of new reports from The Business Research Company that provides brain pacemaker market statistics, including the brain pacemaker industry global market size, regional shares, competitors with brain pacemaker market share, detailed brain pacemaker market segments, market trends, and opportunities, and any further data you may need to thrive in the brain pacemaker industry. These brain pacemaker market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The brain pacemaker market size has grown rapidly in recent years. It will grow from $1.37 billion in 2023 to $1.57 billion in 2024 at a compound annual growth rate (CAGR) of 15.1%. The increase during the historical period can be credited to the rising prevalence of Parkinson's disease, ongoing enhancements in neuromodulation technologies, successful clinical trials and approvals, heightened awareness of movement disorders, and increased healthcare spending.
The brain pacemaker market size is expected to see rapid growth in the next few years. It will grow to $2.77 billion in 2028 at a compound annual growth rate (CAGR) of 15.2%. The growth expected in the forecast period is driven by an aging population, greater awareness and improved diagnostic methods for neurological conditions, broadening of treatment indications, advancements in surgical techniques, regulatory clearances for new devices, and patient preference for non-pharmacological therapies. Key trends anticipated in the forecast period include advanced targeting algorithms, the development of closed-loop DBS systems, integration of wireless charging capabilities, progress in minimally invasive surgical approaches, and innovations in battery technology.
The brain pacemaker market is poised for growth due to increasing neurological illnesses. These disorders affect the nervous system and stem from various factors such as aging, lifestyle choices, environmental influences, genetics, infections, injuries, healthcare disparities, urbanization, and industrialization. Brain pacemakers mitigate neurological symptoms by delivering targeted electrical impulses, thereby enhancing patients' quality of life. As reported in October 2023 by the World Federation of Neurology, over 40% of the global population suffers from neurological conditions, a figure projected to nearly double by 2050. The incidence of stroke deaths globally, currently at 9.7 million annually, is expected to rise by 50% by 2050, further fueling market growth.
Key players in the brain pacemaker sector are advancing technologies such as BrainSense to refine deep brain stimulation therapies. For instance, Medtronic launched the Percept RC deep brain stimulation system in January 2024. This innovative device, featuring BrainSense technology, captures and analyzes brain signals in real time. It enables personalized therapy adjustments, akin to cardiac pacemakers, to optimize treatment outcomes.
In September 2023, Amber Therapeutics, a UK-based company specializing in adaptive neuromodulation therapy, acquired Bioinduction Limited and its Picostim DyNeuMo neuromodulation therapy platform for an undisclosed sum. This acquisition marks a pivotal step for Amber, evolving it into an integrated developer and manufacturer of sophisticated closed-loop neuromodulation therapies. Bioinduction, also based in the UK, manufactures implantable neuromodulation devices, including self-contained cranialized brain pacemakers.
Major companies operating in the brain pacemaker market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, LivaNova PLC, Renishaw plc, Beijing PINS Medical Co. Ltd., NeuroPace Inc., SPR Therapeutics, SceneRay Co. Ltd., Nexeon MedSystems Inc., Soterix Medical Inc., BrainsGate Ltd., Functional Neuromodulation Inc., Aleva Neurotherapeutics SA, NeuroSigma Inc., NeuroOne Medical Technology, Fisher Wallace Laboratories Inc., Bioinduction Limited, Neuronetics Inc., Synchron Inc., Neuro Device Group S.A.
North America was the largest region in the brain pacemaker market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the brain pacemaker market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the brain pacemaker market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The brain pacemaker market consists of sales of patient controller, programming device, extension wires, and pulse generator. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Brain Pacemaker Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on brain pacemaker market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for brain pacemaker ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The brain pacemaker market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
The impact of higher inflation in many countries and the resulting spike in interest rates.
The continued but declining impact of COVID-19 on supply chains and consumption patterns.